The Mitochondrial Theory of Aging posits that aging stems from mitochondrial damage produced during energy metabolism. A vicious cycle results where faulty mitochondria damage DNA, proteins, and lipids. This results in cellular dysfunction and aging. Membrane Lipid Replacement offers a way to reverse the damage to mitochondria due to aging and illnesses like Parkinsons.

Mitochondria are the power house of all cells. Ninety percent (90%) of energy is produced by them. And, they are the primary defense for viruses and toxins. There can be thousands of them in each cell. There are as many as 5,000 in each heart muscle.

Mitochondria are easily stressed. This compromises their effectiveness and survival. This simply put shortens life spans and leads to illness and disease.

The structure and function of mitochondria can be restored with membrane lipid replacement. a therapy discussed in this video with Natural Pharmacist Ross Pelton.

For more information and to order: https://ntfactor.com/

For the research behind Membrane Lipid Replacement visit: www.ntfactor.com/research

Research on Mitochondrial Dysfunction and Parkinsons

Cold Spring Harb Perspect Med. 2025 Jul 28:a041891. The Mitochondrial Connection in Parkinson’s Disease

Abstract

Mitochondria are highly dynamic organelles with complex structural features that perform several essential cellular functions, including energy production by oxidative phosphorylation, regulation of calcium and lipid homeostasis, and control of programmed cell death.

Given their critical role, alterations in mitochondrial biology can lead to neuronal dysfunction and death. Defects in mitochondrial respiration, especially in oxidative energy production, have long been thought to be implicated in the etiology and pathogenesis of Parkinson’s disease.

Given the multifaceted roles of mitochondria in health and diseases, the putative role of mitochondria in Parkinson’s disease likely extends well beyond defective respiration. As such, mitochondrial dysfunction represents a promising target for disease-modifying therapies in Parkinson’s disease and related conditions.

Robert Rodgers PhD
Founder 2004
Parkinsons Recovery ®
https://www.parkinsonsrecovery.com
robert@parkinsonsrecovery.com